Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02885246
Recruitment Status : Completed
First Posted : August 31, 2016
Results First Posted : March 3, 2020
Last Update Posted : April 6, 2020
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

Study Type Observational
Study Design Observational Model: Other;   Time Perspective: Retrospective
Condition Influenza, Human
Intervention Other: Data collection
Enrollment 1839
Recruitment Details This is a database study with no subject enrollment. The seasonal influenza A and/or B cases reported in the study centers were recorded in country specific national influenza surveillance program databases. Data were not available for selected countries of Central America and the Caribbean. Therefore,only data from Panama were analysed.
Pre-assignment Details All data was taken from the Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) database of Panama, from January 2011 to December 2017. Based on the dates of data transfer and data availability, the data collection period was updated as January 2011-December 2017 instead of January 2010-December 2015, previously defined per protocol.
Arm/Group Title Influenza Virus Positive Group
Hide Arm/Group Description The group included specimen samples with a laboratory confirmed diagnosis of influenza A and/or B, reported in the Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) database of Panama, from January 2011 to December 2017.
Period Title: Overall Study
Started 1839
Completed 1839
Not Completed 0
Arm/Group Title Influenza Virus Positive Group
Hide Arm/Group Description The group included specimen samples with a laboratory confirmed diagnosis of influenza A and/or B, reported in the Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) database of Panama, from January 2011 to December 2017.
Overall Number of Baseline Participants 1839
Hide Baseline Analysis Population Description
[Not Specified]
Age, Customized  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 1839 participants
<2 years
567
  30.8%
2-4 years
170
   9.2%
5-19 years
283
  15.4%
20-39 years
313
  17.0%
40-59 years
291
  15.8%
≥60 years
190
  10.3%
Unspecified
25
   1.4%
Sex/Gender, Customized  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 1839 participants
Male
905
  49.2%
Female
909
  49.4%
Unspecified
25
   1.4%
Race and Ethnicity Not Collected   [1] 
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 0 participants
[1]
Measure Analysis Population Description: Race and Ethnicity were not collected from any participant.
1.Primary Outcome
Title Number of Seasonal Influenza A and /or B Cases by Age Group, in Panama (Using the Data Reported Via National Influenza Surveillance Program)
Hide Description The case definition of Influenza was any clinical specimen confirmed by a positive laboratory test. Cases were stratified by the following age categories: less than (<) 2 years; 2-4 years; 5-19 years; 20-39 years; 40-59 years; greater than of equal to (≥) 60 years and Unspecified age, instead of <1, 1-4, 5-9, 10-14, 15-19, 20-24, 25-44, 45-49, 50-59, 60-64 and ≥ 65 years, as initially described in the Protocol. Note that one specimen sample was positive for both influenza A and B so the number started still remains 1839.
Time Frame From January 2011 to December 2017
Hide Outcome Measure Data
Hide Analysis Population Description
The analysis was performed on the Total Cohort which included all specimen samples diagnosed with seasonal influenza A and/or B, reported in the ICGES database of Panama, from January 2011 to December 2017.
Arm/Group Title Influenza Virus Positive Group
Hide Arm/Group Description:
The group included specimen samples with a laboratory confirmed diagnosis of influenza A and/or B, reported in the Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) database of Panama, from January 2011 to December 2017.
Overall Number of Participants Analyzed 1839
Measure Type: Count of Participants
Unit of Measure: Participants
Influenza A <2 years Number Analyzed 567 participants
448
  79.0%
Influenza B <2 years Number Analyzed 567 participants
120
  21.2%
Influenza A 2-4 years Number Analyzed 170 participants
123
  72.4%
Influenza B 2-4 years Number Analyzed 170 participants
47
  27.6%
Influenza A 5-19 years Number Analyzed 283 participants
170
  60.1%
Influenza B 5-19 years Number Analyzed 283 participants
113
  39.9%
Influenza A 20-39 years Number Analyzed 313 participants
274
  87.5%
Influenza B 20-39 years Number Analyzed 313 participants
39
  12.5%
Influenza A 40-59 years Number Analyzed 291 participants
254
  87.3%
Influenza B 40-59 years Number Analyzed 291 participants
37
  12.7%
Influenza A ≥60 Number Analyzed 190 participants
180
  94.7%
Influenza B ≥60 Number Analyzed 190 participants
10
   5.3%
Influenza A Unspecified Number Analyzed 25 participants
15
  60.0%
Influenza B Unspecified Number Analyzed 25 participants
10
  40.0%
Influenza A Total Number Analyzed 1839 participants
1464
  79.6%
Influenza B Total Number Analyzed 1839 participants
376
  20.4%
2.Primary Outcome
Title Number of Seasonal Influenza A Cases by Virus Subtypes, in Panama (Using the Data Reported Via National Influenza Surveillance Program) Among All Influenza Cases A and/or B
Hide Description The case definition of Influenza was any clinical specimen confirmed by a positive laboratory test. Cases were stratified by virus subtype (H1N1 and H3N2) and the following age categories: less than (<) 2 years; 2-4 years; 5-19 years; 20-39 years; 40-59 years; greater than of equal to (≥) 60 years. Note that one specimen sample was positive for both influenza A and B so the number started still remains 1839.
Time Frame From January 2011 to December 2017
Hide Outcome Measure Data
Hide Analysis Population Description
The analysis was performed on the Total Cohort which included all specimen samples diagnosed with seasonal influenza A and/or B, reported in the ICGES database of Panama, from January 2011 to December 2017.
Arm/Group Title Influenza Virus Positive Group
Hide Arm/Group Description:
The group included specimen samples with a laboratory confirmed diagnosis of influenza A and/or B, reported in the Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) database of Panama, from January 2011 to December 2017.
Overall Number of Participants Analyzed 1839
Measure Type: Count of Participants
Unit of Measure: Participants
H1N1 <2 years Number Analyzed 567 participants
259
  45.7%
H3N2 <2 years Number Analyzed 567 participants
189
  33.3%
H1N1 2-4 years Number Analyzed 170 participants
80
  47.1%
H3N2 2-4 years Number Analyzed 170 participants
43
  25.3%
H1N1 5-19 years Number Analyzed 283 participants
119
  42.0%
H3N2 5-19 years Number Analyzed 283 participants
51
  18.0%
H1N1 20-39 years Number Analyzed 313 participants
199
  63.6%
H3N2 20-39 years Number Analyzed 313 participants
75
  24.0%
H1N1 40-59 years Number Analyzed 291 participants
201
  69.1%
H3N2 40-59 years Number Analyzed 291 participants
53
  18.2%
H1N1 ≥60 years Number Analyzed 190 participants
137
  72.1%
H3N2 ≥60 years Number Analyzed 190 participants
43
  22.6%
H1N1 Unspecified Number Analyzed 25 participants
12
  48.0%
H3N2 Unspecified Number Analyzed 25 participants
3
  12.0%
H1N1 Total Number Analyzed 1839 participants
1007
  54.8%
H3N2 Total Number Analyzed 1839 participants
457
  24.9%
3.Primary Outcome
Title Number of Seasonal Influenza B Cases by Strain Lineage, in Panama (Using the Data Reported Via National Influenza Surveillance Program) Among All Influenza Cases A and/or B
Hide Description The case definition of Influenza was any clinical specimen confirmed by a positive laboratory test. Cases were stratified by lineage (Victoria and Yamagata) and the following age categories: less than (<) 2 years; 2-4 years; 5-19 years; 20-39 years; 40-59 years; greater than of equal to (≥) 60 years. Note that one specimen sample was positive for both influenza A and B so the number started still remains 1839.
Time Frame From January 2011 to December 2017
Hide Outcome Measure Data
Hide Analysis Population Description
The analysis was performed on the Total Cohort which included all specimen samples diagnosed with seasonal influenza A and/or B, reported in the ICGES database of Panama, from January 2011 to December 2017.
Arm/Group Title Influenza Virus Positive Group
Hide Arm/Group Description:
The group included specimen samples with a laboratory confirmed diagnosis of influenza A and/or B, reported in the Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) database of Panama, from January 2011 to December 2017.
Overall Number of Participants Analyzed 1839
Measure Type: Count of Participants
Unit of Measure: Participants
Victoria < 2 years Number Analyzed 567 participants
90
  15.9%
Yamagata < 2 years Number Analyzed 567 participants
30
   5.3%
Victoria 2-4 years Number Analyzed 170 participants
36
  21.2%
Yamagata 2-4 years Number Analyzed 170 participants
11
   6.5%
Victoria 5-19 years Number Analyzed 283 participants
84
  29.7%
Yamagata 5-19 years Number Analyzed 283 participants
29
  10.2%
Victoria 20-39 years Number Analyzed 313 participants
30
   9.6%
Yamagata 20-39 years Number Analyzed 313 participants
9
   2.9%
Victoria 40-59 years Number Analyzed 291 participants
13
   4.5%
Yamagata 40-59 years Number Analyzed 291 participants
24
   8.2%
Victoria ≥60 years Number Analyzed 190 participants
8
   4.2%
Yamagata ≥60 years Number Analyzed 190 participants
2
   1.1%
Victoria Unspecified Number Analyzed 25 participants
8
  32.0%
Yamagata Unspecified Number Analyzed 25 participants
2
   8.0%
Victoria Total Number Analyzed 1839 participants
269
  14.6%
Yamagata Total Number Analyzed 1839 participants
107
   5.8%
4.Secondary Outcome
Title Number of Cases With Laboratory Confirmed Diagnosis Seasonal Influenza A and/or B Who Experienced Clinical Features (Clinical Symptoms)
Hide Description The signs and symptoms assessed were: Fever, Cough, Sore throat, Rhinorrhea, Dyspnea, Vomiting, Diarrhea, Myalgias, Nausea, Headache, Wheezing, Apnea, Tachypnea, Polypnea, Arthralgia, Chest Pain, Convulsion, Hyporexia, Weakness, Irritability, Odynophagia, Abdominal pain, Conjunctivitis, Cyanosis and Chills. Each sign and symptom was assessed in four categories: yes = presence of sign/symptom; no = absence of sign/symptom; form not filled = no epi surveillance form available; and unspecified= no data on the Epi surveillance form. Analysis related to duration of the illness was not performed as the data was not collected. Note that one specimen sample was positive for both influenza A and B so the number started still remains 1839.
Time Frame From January 2011 to December 2017
Hide Outcome Measure Data
Hide Analysis Population Description
The analysis was performed on the Total Cohort which included all specimen samples diagnosed with seasonal influenza A and/or B, reported in the ICGES database of Panama, from January 2011 to December 2017.
Arm/Group Title Influenza Virus Positive Group
Hide Arm/Group Description:
The group included specimen samples with a laboratory confirmed diagnosis of influenza A and/or B, reported in the Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) database of Panama, from January 2011 to December 2017.
Overall Number of Participants Analyzed 1839
Measure Type: Count of Participants
Unit of Measure: Participants
Fever-Yes (2011) Number Analyzed 47 participants
41
  87.2%
Fever-No (2011) Number Analyzed 47 participants
4
   8.5%
Fever-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Fever-Unspecified (2011) Number Analyzed 47 participants
2
   4.3%
Cough-Yes (2011) Number Analyzed 47 participants
40
  85.1%
Cough-No (2011) Number Analyzed 47 participants
4
   8.5%
Cough-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Cough-Unspecified (2011) Number Analyzed 47 participants
3
   6.4%
Sore throat-Yes (2011) Number Analyzed 47 participants
26
  55.3%
Sore throat-No (2011) Number Analyzed 47 participants
18
  38.3%
Sore throat-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Sore throat-Unspecified (2011) Number Analyzed 47 participants
3
   6.4%
Rhinorrhea-Yes (2011) Number Analyzed 47 participants
41
  87.2%
Rhinorrhea-No (2011) Number Analyzed 47 participants
3
   6.4%
Rhinorrhea-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Rhinorrhea-Unspecified (2011) Number Analyzed 47 participants
3
   6.4%
Dyspnea-Yes (2011) Number Analyzed 47 participants
4
   8.5%
Dyspnea-No (2011) Number Analyzed 47 participants
32
  68.1%
Dyspnea-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Dyspnea-Unspecified (2011) Number Analyzed 47 participants
11
  23.4%
Vomiting-Yes (2011) Number Analyzed 47 participants
1
   2.1%
Vomiting-No (2011) Number Analyzed 47 participants
38
  80.9%
Vomiting-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Vomiting-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Diarrhea-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Diarrhea-No (2011) Number Analyzed 47 participants
39
  83.0%
Diarrhea-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Diarrhea-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Myalgias-Yes (2011) Number Analyzed 47 participants
1
   2.1%
Myalgias-No (2011) Number Analyzed 47 participants
38
  80.9%
Myalgias-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Myalgias-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Nausea-Yes (2011) Number Analyzed 47 participants
1
   2.1%
Nausea-No (2011) Number Analyzed 47 participants
38
  80.9%
Nausea-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Nausea-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Headache-Yes (2011) Number Analyzed 47 participants
7
  14.9%
Headache-No (2011) Number Analyzed 47 participants
32
  68.1%
Headache-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Headache-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Wheezing-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Wheezing-No (2011) Number Analyzed 47 participants
39
  83.0%
Wheezing-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Wheezing-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Apnea-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Apnea-No (2011) Number Analyzed 47 participants
39
  83.0%
Apnea-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Apnea-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Tachypnea-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Tachypnea-No (2011) Number Analyzed 47 participants
39
  83.0%
Tachypnea-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Tachypnea-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Polypnea-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Polypnea-No (2011) Number Analyzed 47 participants
39
  83.0%
Polypnea-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Polypnea-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Arthralgia-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Arthralgia-No (2011) Number Analyzed 47 participants
39
  83.0%
Arthralgia-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Arthralgia-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Chest Pain-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Chest Pain-No (2011) Number Analyzed 47 participants
39
  83.0%
Chest Pain-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Chest Pain-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Convulsion-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Convulsion-No (2011) Number Analyzed 47 participants
39
  83.0%
Convulsion-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Convulsion-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Hyporexia-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Hyporexia-No (2011) Number Analyzed 47 participants
39
  83.0%
Hyporexia-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Hyporexia-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Weakness-Yes (2011) Number Analyzed 47 participants
4
   8.5%
Weakness-No (2011) Number Analyzed 47 participants
35
  74.5%
Weakness-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Weakness-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Irritability-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Irritability-No (2011) Number Analyzed 47 participants
39
  83.0%
Irritability-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Irritability-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Odynophagia-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Odynophagia-No (2011) Number Analyzed 47 participants
39
  83.0%
Odynophagia-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Odynophagia-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Abdominal pain-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Abdominal pain-No (2011) Number Analyzed 47 participants
39
  83.0%
Abdominal pain-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Abdominal pain-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Conjuntivitis-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Conjuntivitis-No (2011) Number Analyzed 47 participants
39
  83.0%
Conjuntivitis-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Conjuntivitis-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Cyanosis-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Cyanosis-No (2011) Number Analyzed 47 participants
39
  83.0%
Cyanosis-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Cyanosis-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Chills-Yes (2011) Number Analyzed 47 participants
0
   0.0%
Chills-No (2011) Number Analyzed 47 participants
39
  83.0%
Chills-Form not filled (2011) Number Analyzed 47 participants
0
   0.0%
Chills-Unspecified (2011) Number Analyzed 47 participants
8
  17.0%
Fever-Yes (2012) Number Analyzed 275 participants
252
  91.6%
Fever-No (2012) Number Analyzed 275 participants
18
   6.5%
Fever-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Fever-Unspecified (2012) Number Analyzed 275 participants
5
   1.8%
Cough-Yes (2012) Number Analyzed 275 participants
241
  87.6%
Cough-No (2012) Number Analyzed 275 participants
26
   9.5%
Cough-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Cough-Unspecified (2012) Number Analyzed 275 participants
8
   2.9%
Sore throat-Yes (2012) Number Analyzed 275 participants
120
  43.6%
Sore throat- No (2012) Number Analyzed 275 participants
146
  53.1%
Sore throat- Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Sore throat-Unspecified (2012) Number Analyzed 275 participants
9
   3.3%
Rhinorrhea-Yes (2012) Number Analyzed 275 participants
226
  82.2%
Rhinorrhea-No (2012) Number Analyzed 275 participants
40
  14.5%
Rhinorrhea-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Rhinorrhea-Unspecified (2012) Number Analyzed 275 participants
9
   3.3%
Dyspnea-Yes (2012) Number Analyzed 275 participants
27
   9.8%
Dyspnea-No (2012) Number Analyzed 275 participants
169
  61.5%
Dyspnea-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Dyspnea-Unspecified (2012) Number Analyzed 275 participants
79
  28.7%
Vomiting-Yes (2012) Number Analyzed 275 participants
3
   1.1%
Vomiting-No (2012) Number Analyzed 275 participants
203
  73.8%
Vomiting-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Vomiting-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Diarrhea-Yes (2012) Number Analyzed 275 participants
5
   1.8%
Diarrhea-No (2012) Number Analyzed 275 participants
201
  73.1%
Diarrhea-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Diarrhea-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Myalgias-Yes (2012) Number Analyzed 275 participants
2
   0.7%
Myalgias-No (2012) Number Analyzed 275 participants
204
  74.2%
Myalgias- Form not filled(2012) Number Analyzed 275 participants
0
   0.0%
Myalgias-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Nausea-Yes (2012) Number Analyzed 275 participants
2
   0.7%
Nausea-No (2012) Number Analyzed 275 participants
204
  74.2%
Nausea-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Nausea-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Headache-Yes (2012) Number Analyzed 275 participants
33
  12.0%
Headache-No (2012) Number Analyzed 275 participants
173
  62.9%
Headache-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Headache-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Wheezing-Yes (2012) Number Analyzed 275 participants
1
   0.4%
Wheezing-No (2012) Number Analyzed 275 participants
205
  74.5%
Wheezing-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Wheezing-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Apnea-Yes (2012) Number Analyzed 275 participants
1
   0.4%
Apnea-No (2012) Number Analyzed 275 participants
205
  74.5%
Apnea-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Apnea-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Tachypnea-Yes (2012) Number Analyzed 275 participants
0
   0.0%
Tachypnea-No (2012) Number Analyzed 275 participants
206
  74.9%
Tachypnea-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Tachypnea-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Polypnea-Yes (2012) Number Analyzed 275 participants
0
   0.0%
Polypnea-No (2012) Number Analyzed 275 participants
206
  74.9%
Polypnea-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Polypnea-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Arthralgia-Yes (2012) Number Analyzed 275 participants
0
   0.0%
Arthralgia-No (2012) Number Analyzed 275 participants
206
  74.9%
Arthralgia-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Arthralgia-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Chest Pain-Yes (2012) Number Analyzed 275 participants
0
   0.0%
Chest Pain-No (2012) Number Analyzed 275 participants
206
  74.9%
Chest Pain-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Chest Pain-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Convulsion- Yes (2012) Number Analyzed 275 participants
0
   0.0%
Convulsion- No (2012) Number Analyzed 275 participants
206
  74.9%
Convulsion- Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Convulsion- Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Hyporexia-Yes (2012) Number Analyzed 275 participants
0
   0.0%
Hyporexia-No (2012) Number Analyzed 275 participants
206
  74.9%
Hyporexia-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Hyporexia-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Weakness-Yes (2012) Number Analyzed 275 participants
0
   0.0%
Weakness-No (2012) Number Analyzed 275 participants
206
  74.9%
Weakness-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Weakness-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Irritability-Yes (2012) Number Analyzed 275 participants
0
   0.0%
Irritability-No (2012) Number Analyzed 275 participants
206
  74.9%
Irritability-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Irritability-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Odynophagia-Yes (2012) Number Analyzed 275 participants
0
   0.0%
Odynophagia-No (2012) Number Analyzed 275 participants
206
  74.9%
Odynophagia-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Odynophagia-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Abdominal pain-Yes (2012) Number Analyzed 275 participants
0
   0.0%
Abdominal pain-No (2012) Number Analyzed 275 participants
206
  74.9%
Abdominal pain- Form not filled(2012) Number Analyzed 275 participants
0
   0.0%
Abdominal pain-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Conjuntivitis-Yes (2012) Number Analyzed 275 participants
0
   0.0%
Conjuntivitis-No (2012) Number Analyzed 275 participants
206
  74.9%
Conjuntivitis-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Conjuntivitis-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Cyanosis-Yes (2012) Number Analyzed 275 participants
0
   0.0%
Cyanosis-No (2012) Number Analyzed 275 participants
206
  74.9%
Cyanosis-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Cyanosis-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Chills-Yes (2012) Number Analyzed 275 participants
0
   0.0%
Chills-No (2012) Number Analyzed 275 participants
206
  74.9%
Chills-Form not filled (2012) Number Analyzed 275 participants
0
   0.0%
Chills-Unspecified (2012) Number Analyzed 275 participants
69
  25.1%
Fever-Yes (2013) Number Analyzed 190 participants
183
  96.3%
Fever-No (2013) Number Analyzed 190 participants
5
   2.6%
Fever-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Fever-Unspecified (2013) Number Analyzed 190 participants
2
   1.1%
Cough-Yes (2013) Number Analyzed 190 participants
175
  92.1%
Cough-No (2013) Number Analyzed 190 participants
12
   6.3%
Cough-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Cough-Unspecified (2013) Number Analyzed 190 participants
3
   1.6%
Sore throat-Yes (2013) Number Analyzed 190 participants
101
  53.2%
Sore throat-No (2013) Number Analyzed 190 participants
85
  44.7%
Sore throat-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Sore throat-Unspecified (2013) Number Analyzed 190 participants
4
   2.1%
Rhinorrhea-Yes (2013) Number Analyzed 190 participants
168
  88.4%
Rhinorrhea-No (2013) Number Analyzed 190 participants
18
   9.5%
Rhinorrhea-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Rhinorrhea-Unspecified (2013) Number Analyzed 190 participants
4
   2.1%
Dyspnea-Yes (2013) Number Analyzed 190 participants
6
   3.2%
Dyspnea-No (2013) Number Analyzed 190 participants
125
  65.8%
Dyspnea-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Dyspnea-Unspecified (2013) Number Analyzed 190 participants
59
  31.1%
Vomiting-Yes (2013) Number Analyzed 190 participants
3
   1.6%
Vomiting-No (2013) Number Analyzed 190 participants
142
  74.7%
Vomiting-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Vomiting-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Diarrhea-Yes (2013) Number Analyzed 190 participants
1
   0.5%
Diarrhea-No (2013) Number Analyzed 190 participants
144
  75.8%
Diarrhea-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Diarrhea-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Myalgias-Yes (2013) Number Analyzed 190 participants
5
   2.6%
Myalgias-No (2013) Number Analyzed 190 participants
140
  73.7%
Myalgias-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Myalgias-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Nausea-Yes (2013) Number Analyzed 190 participants
2
   1.1%
Nausea-No (2013) Number Analyzed 190 participants
143
  75.3%
Nausea-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Nausea-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Headache-Yes (2013) Number Analyzed 190 participants
16
   8.4%
Headache-No (2013) Number Analyzed 190 participants
129
  67.9%
Headache-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Headache-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Wheezing-Yes (2013) Number Analyzed 190 participants
0
   0.0%
Wheezing-No (2013) Number Analyzed 190 participants
145
  76.3%
Wheezing-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Wheezing-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Apnea-Yes (2013) Number Analyzed 190 participants
0
   0.0%
Apnea-No (2013) Number Analyzed 190 participants
145
  76.3%
Apnea-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Apnea-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Tachypnea-Yes (2013) Number Analyzed 190 participants
0
   0.0%
Tachypnea-No (2013) Number Analyzed 190 participants
145
  76.3%
Tachypnea-Fom not filled (2013) Number Analyzed 190 participants
0
   0.0%
Tachypnea-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Polypnea-Yes (2013) Number Analyzed 190 participants
0
   0.0%
Polypnea-No (2013) Number Analyzed 190 participants
145
  76.3%
Polypnea-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Polypnea-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Arthralgia-Yes (2013) Number Analyzed 190 participants
0
   0.0%
Arthralgia-No (2013) Number Analyzed 190 participants
145
  76.3%
Arthralgia-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Arthralgia-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Chest Pain-Yes (2013) Number Analyzed 190 participants
0
   0.0%
Chest Pain-No (2013) Number Analyzed 190 participants
145
  76.3%
Chest Pain-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Chest Pain-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Convulsion-Yes (2013) Number Analyzed 190 participants
0
   0.0%
Convulsion-No (2013) Number Analyzed 190 participants
145
  76.3%
Convulsion-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Convulsion-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Hyporexia-Yes (2013) Number Analyzed 190 participants
0
   0.0%
Hyporexia-No (2013) Number Analyzed 190 participants
145
  76.3%
Hyporexia-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Hyporexia-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Weakness-Yes (2013) Number Analyzed 190 participants
5
   2.6%
Weakness-No (2013) Number Analyzed 190 participants
140
  73.7%
Weakness-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Weakness-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Irritability-Yes (2013) Number Analyzed 190 participants
0
   0.0%
Irritability-No (2013) Number Analyzed 190 participants
145
  76.3%
Irritability-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Irritability-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Odynophagia-Yes (2013) Number Analyzed 190 participants
0
   0.0%
Odynophagia-No (2013) Number Analyzed 190 participants
145
  76.3%
Odynophagia-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Odynophagia-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Abdominal pain-Yes (2013) Number Analyzed 190 participants
0
   0.0%
Abdominal pain-No (2013) Number Analyzed 190 participants
145
  76.3%
Abdominal pain-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Abdominal pain-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Conjuntivitis-Yes (2013) Number Analyzed 190 participants
0
   0.0%
Conjuntivitis-No (2013) Number Analyzed 190 participants
145
  76.3%
Conjuntivitis-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Conjuntivitis-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Cyanosis-Yes (2013) Number Analyzed 190 participants
0
   0.0%
Cyanosis-No (2013) Number Analyzed 190 participants
145
  76.3%
Cyanosis-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Cyanosis-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Chills-Yes (2013) Number Analyzed 190 participants
2
   1.1%
Chills-No (2013) Number Analyzed 190 participants
143
  75.3%
Chills-Form not filled (2013) Number Analyzed 190 participants
0
   0.0%
Chills-Unspecified (2013) Number Analyzed 190 participants
45
  23.7%
Fever-Yes (2014) Number Analyzed 140 participants
127
  90.7%
Fever-No (2014) Number Analyzed 140 participants
10
   7.1%
Fever-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Fever-Unspecified (2014) Number Analyzed 140 participants
3
   2.1%
Cough-Yes (2014) Number Analyzed 140 participants
125
  89.3%
Cough-No (2014) Number Analyzed 140 participants
12
   8.6%
Cough-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Cough-Unspecified (2014) Number Analyzed 140 participants
3
   2.1%
Sore throat-Yes (2014) Number Analyzed 140 participants
87
  62.1%
Sore throat-No (2014) Number Analyzed 140 participants
44
  31.4%
Sore throat-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Sore throat-Unspecified (2014) Number Analyzed 140 participants
9
   6.4%
Rhinorrhea-Yes (2014) Number Analyzed 140 participants
101
  72.1%
Rhinorrhea-No (2014) Number Analyzed 140 participants
34
  24.3%
Rhinorrhea-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Rhinorrhea-Unspecified (2014) Number Analyzed 140 participants
5
   3.6%
Dyspnea-Yes (2014) Number Analyzed 140 participants
36
  25.7%
Dyspnea-No (2014) Number Analyzed 140 participants
76
  54.3%
Dyspnea-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Dyspnea-Unspecified (2014) Number Analyzed 140 participants
28
  20.0%
Vomiting-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Vomiting-No (2014) Number Analyzed 140 participants
117
  83.6%
Vomiting-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Vomiting-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Diarrhea-Yes (2014) Number Analyzed 140 participants
4
   2.9%
Diarrhea-No (2014) Number Analyzed 140 participants
113
  80.7%
Diarrhea-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Diarrhea-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Myalgias-Yes (2014) Number Analyzed 140 participants
3
   2.1%
Myalgias-No (2014) Number Analyzed 140 participants
114
  81.4%
Myalgias-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Myalgias-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Nausea-Yes (2014) Number Analyzed 140 participants
1
   0.7%
Nausea-No (2014) Number Analyzed 140 participants
116
  82.9%
Nausea-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Nausea-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Headache-Yes (2014) Number Analyzed 140 participants
4
   2.9%
Headache-No (2014) Number Analyzed 140 participants
113
  80.7%
Headache-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Headache-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Wheezing-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Wheezing-No (2014) Number Analyzed 140 participants
117
  83.6%
Wheezing-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Wheezing-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Apnea-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Apnea-No (2014) Number Analyzed 140 participants
117
  83.6%
Apnea-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Apnea-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Tachypnea-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Tachypnea-No (2014) Number Analyzed 140 participants
117
  83.6%
Tachypnea-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Tachypnea-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Polypnea-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Polypnea-No (2014) Number Analyzed 140 participants
117
  83.6%
Polypnea-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Polypnea-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Arthralgia-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Arthralgia-No (2014) Number Analyzed 140 participants
117
  83.6%
Arthralgia-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Arthralgia-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Chest Pain-Yes (2014) Number Analyzed 140 participants
1
   0.7%
Chest Pain-No (2014) Number Analyzed 140 participants
116
  82.9%
Chest Pain-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Chest Pain-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Convulsion-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Convulsion-No (2014) Number Analyzed 140 participants
117
  83.6%
Convulsion-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Convulsion-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Hyporexia-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Hyporexia-No (2014) Number Analyzed 140 participants
117
  83.6%
Hyporexia-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Hyporexia-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Weakness-Yes (2014) Number Analyzed 140 participants
3
   2.1%
Weakness-No (2014) Number Analyzed 140 participants
114
  81.4%
Weakness-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Weakness-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Irritability-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Irritability-No (2014) Number Analyzed 140 participants
117
  83.6%
Irritability-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Irritability-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Odynophagia-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Odynophagia-No (2014) Number Analyzed 140 participants
117
  83.6%
Odynophagia-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Odynophagia-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Abdominal pain-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Abdominal pain-No (2014) Number Analyzed 140 participants
117
  83.6%
Abdominal pain-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Abdominal pain-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Conjuntivitis-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Conjuntivitis-No (2014) Number Analyzed 140 participants
117
  83.6%
Conjuntivitis-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Conjuntivitis-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Cyanosis-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Cyanosis-No (2014) Number Analyzed 140 participants
117
  83.6%
Cyanosis-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Cyanosis-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Chills-Yes (2014) Number Analyzed 140 participants
0
   0.0%
Chills-No (2014) Number Analyzed 140 participants
117
  83.6%
Chills-Form not filled (2014) Number Analyzed 140 participants
0
   0.0%
Chills-Unspecified (2014) Number Analyzed 140 participants
23
  16.4%
Fever-Yes (2015) Number Analyzed 100 participants
85
  85.0%
Fever-No (2015) Number Analyzed 100 participants
14
  14.0%
Fever-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Fever-Unspecified (2015) Number Analyzed 100 participants
1
   1.0%
Cough-Yes (2015) Number Analyzed 100 participants
88
  88.0%
Cough-No (2015) Number Analyzed 100 participants
11
  11.0%
Cough-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Cough-Unspecified (2015) Number Analyzed 100 participants
1
   1.0%
Sore throat-Yes (2015) Number Analyzed 100 participants
21
  21.0%
Sore throat-No (2015) Number Analyzed 100 participants
74
  74.0%
Sore throat-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Sore throat-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Rhinorrhea-Yes (2015) Number Analyzed 100 participants
67
  67.0%
Rhinorrhea-No (2015) Number Analyzed 100 participants
32
  32.0%
Rhinorrhea-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Rhinorrhea-Unspecified (2015) Number Analyzed 100 participants
1
   1.0%
Dyspnea-Yes (2015) Number Analyzed 100 participants
59
  59.0%
Dyspnea-No (2015) Number Analyzed 100 participants
36
  36.0%
Dyspnea-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Dyspnea-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Vomiting-Yes (2015) Number Analyzed 100 participants
1
   1.0%
Vomiting-No (2015) Number Analyzed 100 participants
94
  94.0%
Vomiting-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Vomiting-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Diarrhea-Yes (2015) Number Analyzed 100 participants
2
   2.0%
Diarrhea-No (2015) Number Analyzed 100 participants
93
  93.0%
Diarrhea-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Diarrhea-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Myalgias-Yes (2015) Number Analyzed 100 participants
0
   0.0%
Myalgias-No (2015) Number Analyzed 100 participants
95
  95.0%
Myalgias-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Myalgias-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Nausea-Yes (2015) Number Analyzed 100 participants
0
   0.0%
Nausea-No (2015) Number Analyzed 100 participants
95
  95.0%
Nausea-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Nausea-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Headache-Yes (2015) Number Analyzed 100 participants
2
   2.0%
Headache-No (2015) Number Analyzed 100 participants
93
  93.0%
Headache-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Headache-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Wheezing-Yes (2015) Number Analyzed 100 participants
1
   1.0%
Wheezing-No (2015) Number Analyzed 100 participants
94
  94.0%
Wheezing-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Wheezing-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Apnea-Yes (2015) Number Analyzed 100 participants
1
   1.0%
Apnea-No (2015) Number Analyzed 100 participants
94
  94.0%
Apnea-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Apnea-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Tachypnea-Yes (2015) Number Analyzed 100 participants
0
   0.0%
Tachypnea-No (2015) Number Analyzed 100 participants
95
  95.0%
Tachypnea-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Tachypnea-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Polypnea-Yes (2015) Number Analyzed 100 participants
0
   0.0%
Polypnea-No (2015) Number Analyzed 100 participants
95
  95.0%
Polypnea-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Polypnea-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Arthralgia-Yes (2015) Number Analyzed 100 participants
2
   2.0%
Arthralgia-No (2015) Number Analyzed 100 participants
93
  93.0%
Arthralgia-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Arthralgia-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Chest Pain-Yes (2015) Number Analyzed 100 participants
1
   1.0%
Chest Pain-No (2015) Number Analyzed 100 participants
94
  94.0%
Chest Pain-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Chest Pain-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Convulsion-Yes (2015) Number Analyzed 100 participants
1
   1.0%
Convulsion-No (2015) Number Analyzed 100 participants
94
  94.0%
Convulsion-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Convulsion-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Hyporexia-Yes (2015) Number Analyzed 100 participants
0
   0.0%
Hyporexia-No (2015) Number Analyzed 100 participants
95
  95.0%
Hyporexia-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Hyporexia-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Weakness-Yes (2015) Number Analyzed 100 participants
0
   0.0%
Weakness-No (2015) Number Analyzed 100 participants
95
  95.0%
Weakness-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Weakness-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Irritability-Yes (2015) Number Analyzed 100 participants
0
   0.0%
Irritability-No (2015) Number Analyzed 100 participants
95
  95.0%
Irritability-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Irritability-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Odynophagia-Yes (2015) Number Analyzed 100 participants
0
   0.0%
Odynophagia-No (2015) Number Analyzed 100 participants
95
  95.0%
Odynophagia-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Odynophagia-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Abdominal pain-Yes (2015) Number Analyzed 100 participants
0
   0.0%
Abdominal pain-No (2015) Number Analyzed 100 participants
95
  95.0%
Abdominal pain-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Abdominal pain-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Conjuntivitis-Yes (2015) Number Analyzed 100 participants
0
   0.0%
Conjuntivitis-No (2015) Number Analyzed 100 participants
95
  95.0%
Conjuntivitis-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Conjuntivitis-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Cyanosis-Yes (2015) Number Analyzed 100 participants
0
   0.0%
Cyanosis-No (2015) Number Analyzed 100 participants
95
  95.0%
Cyanosis-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Cyanosis-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Chills-Yes (2015) Number Analyzed 100 participants
1
   1.0%
Chills-No (2015) Number Analyzed 100 participants
94
  94.0%
Chills-Form not filled (2015) Number Analyzed 100 participants
0
   0.0%
Chills-Unspecified (2015) Number Analyzed 100 participants
5
   5.0%
Fever-Yes (2016) Number Analyzed 827 participants
686
  83.0%
Fever-No (2016) Number Analyzed 827 participants
80
   9.7%
Fever-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Fever-Unspecified (2016) Number Analyzed 827 participants
37
   4.5%
Cough-Yes (2016) Number Analyzed 827 participants
710
  85.9%
Cough-No (2016) Number Analyzed 827 participants
49
   5.9%
Cough-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Cough-Unspecified (2016) Number Analyzed 827 participants
44
   5.3%
Sore throat-Yes (2016) Number Analyzed 827 participants
351
  42.4%
Sore throat-No (2016) Number Analyzed 827 participants
356
  43.0%
Sore throat-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Sore throat-Unspecified (2016) Number Analyzed 827 participants
96
  11.6%
Rhinorrhea-Yes (2016) Number Analyzed 827 participants
480
  58.0%
Rhinorrhea-No (2016) Number Analyzed 827 participants
256
  31.0%
Rhinorrhea-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Rhinorrhea-Unspecified (2016) Number Analyzed 827 participants
67
   8.1%
Dyspnea-Yes (2016) Number Analyzed 827 participants
372
  45.0%
Dyspnea-No (2016) Number Analyzed 827 participants
352
  42.6%
Dyspnea-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Dyspnea-Unspecified (2016) Number Analyzed 827 participants
78
   9.4%
Dyspnea-Missing (2016) Number Analyzed 827 participants
1
   0.1%
Vomiting-Yes (2016) Number Analyzed 827 participants
25
   3.0%
Vomiting- No (2016) Number Analyzed 827 participants
693
  83.8%
Vomiting-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Vomiting-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Diarrhea-Yes (2016) Number Analyzed 827 participants
25
   3.0%
Diarrhea-No (2016) Number Analyzed 827 participants
693
  83.8%
Diarrhea-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Diarrhea-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Myalgias-Yes (2016) Number Analyzed 827 participants
28
   3.4%
Myalgias-No (2016) Number Analyzed 827 participants
690
  83.4%
Myalgias-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Myalgias-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Nausea-Yes (2016) Number Analyzed 827 participants
3
   0.4%
Nausea-No (2016) Number Analyzed 827 participants
715
  86.5%
Nausea-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Nausea-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Headache-Yes (2016) Number Analyzed 827 participants
45
   5.4%
Headache-No (2016) Number Analyzed 827 participants
673
  81.4%
Headache-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Headache-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Wheezing-Yes (2016) Number Analyzed 827 participants
0
   0.0%
Wheezing-No (2016) Number Analyzed 827 participants
718
  86.8%
Wheezing-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Wheezing-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Apnea-Yes (2016) Number Analyzed 827 participants
0
   0.0%
Apnea-No (2016) Number Analyzed 827 participants
718
  86.8%
Apnea-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Apnea-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Tachypnea-Yes (2016) Number Analyzed 827 participants
2
   0.2%
Tachypnea-No (2016) Number Analyzed 827 participants
716
  86.6%
Tachypnea-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Tachypnea-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Polypnea-Yes (2016) Number Analyzed 827 participants
0
   0.0%
Polypnea-No (2016) Number Analyzed 827 participants
718
  86.8%
Polypnea-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Polypnea-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Arthralgia-Yes (2016) Number Analyzed 827 participants
7
   0.8%
Arthralgia-No (2016) Number Analyzed 827 participants
711
  86.0%
Arthralgia-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Arthralgia-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Chest Pain-Yes 2016) Number Analyzed 827 participants
3
   0.4%
Chest Pain-No (2016) Number Analyzed 827 participants
715
  86.5%
Chest Pain-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Chest Pain-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Convulsion-Yes 2016) Number Analyzed 827 participants
5
   0.6%
Convulsion-No (2016) Number Analyzed 827 participants
713
  86.2%
Convulsion-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Convulsion-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Hyporexia-Yes (2016) Number Analyzed 827 participants
7
   0.8%
Hyporexia-No (2016) Number Analyzed 827 participants
711
  86.0%
Hyporexia-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Hyporexia-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Weakness-Yes (2016) Number Analyzed 827 participants
95
  11.5%
Weakness-No (2016) Number Analyzed 827 participants
623
  75.3%
Weakness-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Weakness-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Irritability-Yes (2016) Number Analyzed 827 participants
0
   0.0%
Irritability-No (2016) Number Analyzed 827 participants
718
  86.8%
Irritability-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Irritability-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Odynophagia-Yes (2016) Number Analyzed 827 participants
1
   0.1%
Odynophagia-No (2016) Number Analyzed 827 participants
717
  86.7%
Odynophagia-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Odynophagia-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Abdominal pain-Yes (2016) Number Analyzed 827 participants
1
   0.1%
Abdominal pain-No (2016) Number Analyzed 827 participants
717
  86.7%
Abdominal pain-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Abdominal pain-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Conjuntivitis-Yes (2016) Number Analyzed 827 participants
3
   0.4%
Conjuntivitis-No (2016) Number Analyzed 827 participants
715
  86.5%
Conjuntivitis-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Conjuntivitis-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Cyanosis-Yes (2016) Number Analyzed 827 participants
1
   0.1%
Cyanosis-No (2016) Number Analyzed 827 participants
717
  86.7%
Cyanosis-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Cyanosis-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Chills-Yes (2016) Number Analyzed 827 participants
7
   0.8%
Chills-No (2016) Number Analyzed 827 participants
711
  86.0%
Chills-Form not filled (2016) Number Analyzed 827 participants
24
   2.9%
Chills-Unspecified (2016) Number Analyzed 827 participants
85
  10.3%
Fever-Yes (2017) Number Analyzed 260 participants
211
  81.2%
Fever-No (2017) Number Analyzed 260 participants
42
  16.2%
Fever-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Fever-Unspecified (2017) Number Analyzed 260 participants
7
   2.7%
Cough-Yes (2017) Number Analyzed 260 participants
220
  84.6%
Cough-No (2017) Number Analyzed 260 participants
33
  12.7%
Cough-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Cough-Unspecified (2017) Number Analyzed 260 participants
7
   2.7%
Sore throat-Yes (2017) Number Analyzed 260 participants
48
  18.5%
Sore throat-No (2017) Number Analyzed 260 participants
185
  71.2%
Sore throat-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Sore throat-Unspecified (2017) Number Analyzed 260 participants
27
  10.4%
Rhinorrhea-Yes (2017) Number Analyzed 260 participants
189
  72.7%
Rhinorrhea-No (2017) Number Analyzed 260 participants
56
  21.5%
Rhinorrhea-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Rhinorrhea-Unspecified (2017) Number Analyzed 260 participants
15
   5.8%
Dyspnea-Yes (2017) Number Analyzed 260 participants
125
  48.1%
Dyspnea-No (2017) Number Analyzed 260 participants
101
  38.8%
Dyspnea-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Dyspnea-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Vomiting-Yes (2017) Number Analyzed 260 participants
7
   2.7%
Vomiting-No (2017) Number Analyzed 260 participants
219
  84.2%
Vomiting-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Vomiting-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Diarrhea-Yes (2017) Number Analyzed 260 participants
6
   2.3%
Diarrhea-No (2017) Number Analyzed 260 participants
220
  84.6%
Diarrhea-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Diarrhea-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Myalgias-Yes (2017) Number Analyzed 260 participants
4
   1.5%
Myalgias-No (2017) Number Analyzed 260 participants
222
  85.4%
Myalgias-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Myalgias-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Nausea-Yes (2017) Number Analyzed 260 participants
0
   0.0%
Nausea-No (2017) Number Analyzed 260 participants
226
  86.9%
Nausea-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Nausea-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Headache-Yes (2017) Number Analyzed 260 participants
10
   3.8%
Headache-No (2017) Number Analyzed 260 participants
216
  83.1%
Headache-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Headache-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Wheezing-Yes (2017) Number Analyzed 260 participants
1
   0.4%
Wheezing-No (2017) Number Analyzed 260 participants
225
  86.5%
Wheezing-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Wheezing-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Apnea-Yes (2017) Number Analyzed 260 participants
0
   0.0%
Apnea-No (2017) Number Analyzed 260 participants
226
  86.9%
Apnea-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Apnea-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Tachypnea-Yes (2017) Number Analyzed 260 participants
0
   0.0%
Tachypnea-No (2017) Number Analyzed 260 participants
226
  86.9%
Tachypnea-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Tachypnea-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Polypnea-Yes (2017) Number Analyzed 260 participants
0
   0.0%
Polypnea-No (2017) Number Analyzed 260 participants
226
  86.9%
Polypnea-Fom not filled (2017) Number Analyzed 260 participants
0
   0.0%
Polypnea-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Arthralgia-Yes (2017) Number Analyzed 260 participants
2
   0.8%
Arthralgia-No (2017) Number Analyzed 260 participants
224
  86.2%
Arthralgia-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Arthralgia-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Chest Pain-Yes (2017) Number Analyzed 260 participants
1
   0.4%
Chest Pain-No (2017) Number Analyzed 260 participants
225
  86.5%
Chest Pain-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Chest Pain-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Convulsion-Yes (2017) Number Analyzed 260 participants
2
   0.8%
Convulsion-No (2017) Number Analyzed 260 participants
224
  86.2%
Convulsion-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Convulsion-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Hyporexia-Yes (2017) Number Analyzed 260 participants
9
   3.5%
Hyporexia-No (2017) Number Analyzed 260 participants
217
  83.5%
Hyporexia-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Hyporexia-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Weakness-Yes (2017) Number Analyzed 260 participants
9
   3.5%
Weakness-No (2017) Number Analyzed 260 participants
217
  83.5%
Weakness-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Weakness-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Irritability-Yes (2017) Number Analyzed 260 participants
7
   2.7%
Irritability-No (2017) Number Analyzed 260 participants
219
  84.2%
Irritability-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Irritability-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Odynophagia-Yes (2017) Number Analyzed 260 participants
0
   0.0%
Odynophagia-No (2017) Number Analyzed 260 participants
226
  86.9%
Odynophagia-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Odynophagia-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Abdominal pain-Yes (2017) Number Analyzed 260 participants
1
   0.4%
Abdominal pain-No (2017) Number Analyzed 260 participants
225
  86.5%
Abdominal pain-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Abdominal pain-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Conjuntivitis-Yes (2017) Number Analyzed 260 participants
0
   0.0%
Conjuntivitis-No (2017) Number Analyzed 260 participants
226
  86.9%
Conjuntivitis-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Conjuntivitis-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Cyanosis-Yes (2017) Number Analyzed 260 participants
0
   0.0%
Cyanosis-No (2017) Number Analyzed 260 participants
226
  86.9%
Cyanosis- Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Cyanosis-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Chills-Yes (2017) Number Analyzed 260 participants
0
   0.0%
Chills-No (2017) Number Analyzed 260 participants
226
  86.9%
Chills-Form not filled (2017) Number Analyzed 260 participants
0
   0.0%
Chills-Unspecified (2017) Number Analyzed 260 participants
34
  13.1%
Fever - Yes (Total) Number Analyzed 1839 participants
1585
  86.2%
Fever - No (Total) Number Analyzed 1839 participants
173
   9.4%
Fever - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Fever - Unspecified (Total) Number Analyzed 1839 participants
57
   3.1%
Cough - Yes (Total) Number Analyzed 1839 participants
1599
  86.9%
Cough - No (Total) Number Analyzed 1839 participants
147
   8.0%
Cough - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Cough - Unspecified (Total) Number Analyzed 1839 participants
69
   3.8%
Sore throat - Yes (Total) Number Analyzed 1839 participants
754
  41.0%
Sore throat - No (Total) Number Analyzed 1839 participants
908
  49.4%
Sore throat - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Sore throat - Unspecified (Total) Number Analyzed 1839 participants
153
   8.3%
Rhinorrhea - Yes (Total) Number Analyzed 1839 participants
1272
  69.2%
Rhinorrhea - No (Total) Number Analyzed 1839 participants
439
  23.9%
Rhinorrhea - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Rhinorrhea - Unspecified (Total) Number Analyzed 1839 participants
104
   5.7%
Dyspnea - Yes (Total) Number Analyzed 1839 participants
629
  34.2%
Dyspnea - No (Total) Number Analyzed 1839 participants
891
  48.5%
Dyspnea - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Dyspnea - Unspecified (Total) Number Analyzed 1839 participants
294
  16.0%
Dyspnea - Missing (Total) Number Analyzed 1839 participants
1
   0.1%
Vomiting -Yes (Total) Number Analyzed 1839 participants
40
   2.2%
Vomiting - No(Total) Number Analyzed 1839 participants
1506
  81.9%
Vomiting - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Vomiting - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Diarrhea - Yes (Total) Number Analyzed 1839 participants
43
   2.3%
Diarrhea - No (Total) Number Analyzed 1839 participants
1503
  81.7%
Diarrhea - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Diarrhea - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Myalgias - Yes (Total) Number Analyzed 1839 participants
43
   2.3%
Myalgias - No (Total) Number Analyzed 1839 participants
1503
  81.7%
Myalgias - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Myalgias - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Nausea - Yes (Total) Number Analyzed 1839 participants
9
   0.5%
Nausea - No (Total) Number Analyzed 1839 participants
1537
  83.6%
Nausea - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Nausea - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Headache - Yes (Total) Number Analyzed 1839 participants
117
   6.4%
Headache - No (Total) Number Analyzed 1839 participants
1429
  77.7%
Headache - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Headache - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Wheezing - Yes (Total) Number Analyzed 1839 participants
3
   0.2%
Wheezing - No (Total) Number Analyzed 1839 participants
1543
  83.9%
Wheezing - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Wheezing - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Apnea - Yes (Total) Number Analyzed 1839 participants
2
   0.1%
Apnea - No (Total) Number Analyzed 1839 participants
1544
  84.0%
Apnea - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Apnea - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Tachypnea - Yes (Total) Number Analyzed 1839 participants
2
   0.1%
Tachypnea - No (Total) Number Analyzed 1839 participants
1544
  84.0%
Tachypnea - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Tachypnea - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Polypnea - Yes (Total) Number Analyzed 1839 participants
0
   0.0%
Polypnea - No (Total) Number Analyzed 1839 participants
1546
  84.1%
Polypnea - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Polypnea - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Arthralgia - Yes (Total) Number Analyzed 1839 participants
11
   0.6%
Arthralgia - No (Total) Number Analyzed 1839 participants
1535
  83.5%
Arthralgia - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Arthralgia - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Chest Pain - Yes (Total) Number Analyzed 1839 participants
6
   0.3%
Chest Pain - No (Total) Number Analyzed 1839 participants
1540
  83.7%
Chest Pain - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Chest Pain - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Convulsion - Yes (Total) Number Analyzed 1839 participants
8
   0.4%
Convulsion - No (Total) Number Analyzed 1839 participants
1538
  83.6%
Convulsion - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Convulsion - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Hyporexia- Yes (Total) Number Analyzed 1839 participants
16
   0.9%
Hyporexia- No (Total) Number Analyzed 1839 participants
1530
  83.2%
Hyporexia- Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Hyporexia- Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Weakness - Yes (Total) Number Analyzed 1839 participants
116
   6.3%
Weakness - No (Total) Number Analyzed 1839 participants
1430
  77.8%
Weakness - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Weakness - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Irritability - Yes (Total) Number Analyzed 1839 participants
7
   0.4%
Irritability - No (Total) Number Analyzed 1839 participants
1539
  83.7%
Irritability - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Irritability - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Odynophagia - Yes (Total) Number Analyzed 1839 participants
1
   0.1%
Odynophagia - No (Total) Number Analyzed 1839 participants
1545
  84.0%
Odynophagia - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Odynophagia - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Abdominal pain - Yes (Total) Number Analyzed 1839 participants
2
   0.1%
Abdominal pain - No (Total) Number Analyzed 1839 participants
1544
  84.0%
Abdominal pain - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Abdominal pain - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Conjuntivitis - Yes (Total) Number Analyzed 1839 participants
3
   0.2%
Conjuntivitis - No (Total) Number Analyzed 1839 participants
1543
  83.9%
Conjuntivitis - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Conjuntivitis - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Cyanosis - Yes (Total) Number Analyzed 1839 participants
1
   0.1%
Cyanosis - No (Total) Number Analyzed 1839 participants
1545
  84.0%
Cyanosis - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Cyanosis - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
Chills - Yes (Total) Number Analyzed 1839 participants
10
   0.5%
Chills - No (Total) Number Analyzed 1839 participants
1536
  83.5%
Chills - Form not filled (Total) Number Analyzed 1839 participants
24
   1.3%
Chills - Unspecified (Total) Number Analyzed 1839 participants
269
  14.6%
5.Secondary Outcome
Title Number of Cases With Laboratory Confirmed Diagnosis Seasonal Influenza A and/or B Who Experienced Outcomes (Complications)
Hide Description The outcomes were categorized as follows: Outpatient, Hospitalised, Dead or Unspecified (i.e. missing data on the epidemiology surveillance form). Note that one specimen sample was positive for both influenza A and B so the number started still remains 1839.
Time Frame From January 2011 to December 2017
Hide Outcome Measure Data
Hide Analysis Population Description
The analysis was performed on the Total Cohort which included specimen samples diagnosed with seasonal influenza A and/or B, reported in the ICGES database of Panama, from January 2011 to December 2017.
Arm/Group Title Influenza Virus Positive Group
Hide Arm/Group Description:
The group included specimen samples with a laboratory confirmed diagnosis of influenza A and/or B, reported in the Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) database of Panama, from January 2011 to December 2017.
Overall Number of Participants Analyzed 1839
Measure Type: Count of Participants
Unit of Measure: Participants
Outpatient (2011) Number Analyzed 47 participants
37
  78.7%
Hospitalised (2011) Number Analyzed 47 participants
10
  21.3%
Dead (2011) Number Analyzed 47 participants
0
   0.0%
Unspecified (2011) Number Analyzed 47 participants
0
   0.0%
Outpatient (2012) Number Analyzed 275 participants
132
  48.0%
Hospitalised (2012) Number Analyzed 275 participants
79
  28.7%
Dead (2012) Number Analyzed 275 participants
0
   0.0%
Unspecified (2012) Number Analyzed 275 participants
64
  23.3%
Outpatient (2013) Number Analyzed 190 participants
119
  62.6%
Hospitalised (2013) Number Analyzed 190 participants
59
  31.1%
Dead (2013) Number Analyzed 190 participants
0
   0.0%
Unspecified (2013) Number Analyzed 190 participants
12
   6.3%
Outpatient (2014) Number Analyzed 140 participants
90
  64.3%
Hospitalised (2014) Number Analyzed 140 participants
50
  35.7%
Dead (2014) Number Analyzed 140 participants
0
   0.0%
Unspecified (2014) Number Analyzed 140 participants
0
   0.0%
Outpatient (2015) Number Analyzed 100 participants
24
  24.0%
Hospitalised (2015) Number Analyzed 100 participants
76
  76.0%
Dead (2015) Number Analyzed 100 participants
0
   0.0%
Unspecified (2015) Number Analyzed 100 participants
0
   0.0%
Outpatient (2016) Number Analyzed 827 participants
338
  40.9%
Hospitalised (2016) Number Analyzed 827 participants
465
  56.2%
Dead (2016) Number Analyzed 827 participants
10
   1.2%
Unspecified (2016) Number Analyzed 827 participants
14
   1.7%
Outpatient (2017) Number Analyzed 260 participants
66
  25.4%
Hospitalised (2017) Number Analyzed 260 participants
192
  73.8%
Dead (2017) Number Analyzed 260 participants
1
   0.4%
Unspecified (2017) Number Analyzed 260 participants
1
   0.4%
Outpatient (Total) Number Analyzed 1839 participants
806
  43.8%
Hospitalised (Total) Number Analyzed 1839 participants
931
  50.6%
Dead (Total) Number Analyzed 1839 participants
11
   0.6%
Unspecified (Total) Number Analyzed 1839 participants
91
   4.9%
6.Secondary Outcome
Title Number of Seasonal Influenza A and /or B Cases by Southern Hemisphere, Within Different Seasons From 2011 to 2017
Hide Description The cases were stratified by influenza type and Southern hemisphere Influenza seasonal period (May-October of each year 2011-2017). Note that one specimen sample was positive for both influenza A and B so the number started still remains 1839.
Time Frame Within the Southern hemisphere influenza seasons (May to October of each year 2011-2017)
Hide Outcome Measure Data
Hide Analysis Population Description
The analysis was performed on the Total Cohort which included all specimen samples diagnosed with seasonal influenza A and/or B, reported in the ICGES database of Panama, within the Southern hemisphere influenza seasons (May to October of each year 2011-2017).
Arm/Group Title Influenza Virus Positive Group
Hide Arm/Group Description:
The group included specimen samples with a laboratory confirmed diagnosis of influenza A and/or B, reported in the Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) database of Panama, from January 2011 to December 2017.
Overall Number of Participants Analyzed 1580
Measure Type: Count of Participants
Unit of Measure: Participants
Influenza A (May-Oct 2011) Number Analyzed 41 participants
41
 100.0%
Influenza B (May-Oct 2011) Number Analyzed 41 participants
0
   0.0%
Influenza A (May-Oct 2012) Number Analyzed 264 participants
93
  35.2%
Influenza B (May-Oct 2012) Number Analyzed 264 participants
172
  65.2%
Influenza A (May-Oct 2013) Number Analyzed 177 participants
177
 100.0%
Influenza B (May-Oct 2013) Number Analyzed 177 participants
0
   0.0%
Influenza A (May-Oct 2014) Number Analyzed 104 participants
50
  48.1%
Influenza B (May-Oct 2014) Number Analyzed 104 participants
54
  51.9%
Influenza A (May-Oct 2015) Number Analyzed 74 participants
74
 100.0%
Influenza B (May-Oct 2015) Number Analyzed 74 participants
0
   0.0%
Influenza A (May-Oct 2016) Number Analyzed 698 participants
698
 100.0%
Influenza B (May-Oct 2016) Number Analyzed 698 participants
0
   0.0%
Influenza A (May-Oct 2017) Number Analyzed 222 participants
91
  41.0%
Influenza B (May-Oct 2017) Number Analyzed 222 participants
131
  59.0%
Influenza A (total for all seasons 2011-2017) Number Analyzed 1580 participants
1224
  77.5%
Influenza B (total for all seasons (2011-2017) Number Analyzed 1580 participants
357
  22.6%
7.Secondary Outcome
Title Number of Seasonal Influenza A and /or B Cases by Region, Within Study Period From 2011 to 2017
Hide Description The cases were stratified by region. Regions were classified as follows: West, Central, Panama, Northeast, Unspecified (= region unknown). Note that one specimen sample was positive for both influenza A and B so the number started still remains 1839.
Time Frame From January 2011 to December 2017
Hide Outcome Measure Data
Hide Analysis Population Description
The analysis was performed on the Total Cohort which included all specimen samples diagnosed with seasonal influenza A and/or B, reported in the ICGES database of Panama, from January 2011 to December 2017.
Arm/Group Title Influenza Virus Positive Group
Hide Arm/Group Description:
The group included specimen samples with a laboratory confirmed diagnosis of influenza A and/or B, reported in the Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) database of Panama, from January 2011 to December 2017.
Overall Number of Participants Analyzed 1839
Measure Type: Count of Participants
Unit of Measure: Participants
Influenza A (West) Number Analyzed 427 participants
345
  80.8%
Influenza B (West) Number Analyzed 427 participants
82
  19.2%
Influenza A (Central) Number Analyzed 308 participants
244
  79.2%
Influenza B (Central) Number Analyzed 308 participants
64
  20.8%
Influenza A (Panama) Number Analyzed 1006 participants
805
  80.0%
Influenza B (Panama) Number Analyzed 1006 participants
201
  20.0%
Influenza A (Northeast) Number Analyzed 59 participants
48
  81.4%
Influenza B (Northeast) Number Analyzed 59 participants
12
  20.3%
Influenza A (Unspecified) Number Analyzed 39 participants
22
  56.4%
Influenza B (Unspecified) Number Analyzed 39 participants
17
  43.6%
Influenza A (Total) Number Analyzed 1839 participants
1464
  79.6%
Influenza B (Total) Number Analyzed 1839 participants
376
  20.4%
8.Secondary Outcome
Title Number of Influenza Cases Caused by B- Strain and Presented by B-lineage and by Region Among All Influenza Cases A and/or B
Hide Description The cases were stratified by lineage (Victoria and Yamagata) and region. Regions were classified as follows: West, Central, Panama, Northeast, Unspecified (= region unknown). Note that one specimen sample was positive for both influenza A and B so the number started still remains 1839.
Time Frame From January 2011 to December 2017
Hide Outcome Measure Data
Hide Analysis Population Description
The analysis was performed on the Total Cohort which included all specimen samples diagnosed with seasonal influenza A and/or B, reported in the ICGES database of Panama, from January 2011 to December 2017.
Arm/Group Title Influenza Virus Positive Group
Hide Arm/Group Description:
The group included specimen samples with a laboratory confirmed diagnosis of influenza A and/or B, reported in the Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) database of Panama, from January 2011 to December 2017.
Overall Number of Participants Analyzed 1839
Measure Type: Count of Participants
Unit of Measure: Participants
Victoria (West) Number Analyzed 427 participants
61
  14.3%
Yamagata (West) Number Analyzed 427 participants
21
   4.9%
Victoria (Central) Number Analyzed 308 participants
48
  15.6%
Yamagata (Central) Number Analyzed 308 participants
16
   5.2%
Victoria (Panama) Number Analyzed 1006 participants
138
  13.7%
Yamagata (Panama) Number Analyzed 1006 participants
63
   6.3%
Victoria (Northeast) Number Analyzed 59 participants
5
   8.5%
Yamagata (Northeast) Number Analyzed 59 participants
7
  11.9%
Victoria (Unspecified) Number Analyzed 39 participants
17
  43.6%
Yamagata (Unspecified) Number Analyzed 39 participants
0
   0.0%
Victoria (Total) Number Analyzed 1839 participants
269
  14.6%
Yamagata (Total) Number Analyzed 1839 participants
107
   5.8%
9.Secondary Outcome
Title Number of Circulating Influenza B Lineage Positive Specimens Mismatch With the B-strain Vaccine Recommendation, Among the Number of Influenza B Positive Specimens, by Influenza Seasons
Hide Description Comparison of characteristics of the influenza B-infection Victoria (V) or Yamagata (Y) as observed in the database and the B-strain included in the trivalent influenza vaccine expressed as the number of cases with B-lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses observed during the study period. Categories are defined as follows: e.g. for the first category:"V.(B/Brisbane/60/2008)vsVictoria-May-Oct 2011" corresponds to Southern hemisphere influenza season of "May-Oct 2011" with vaccine recommendation: "Victoria (B/Brisbane/60/2008-like virus)" compared to circulating Influenza B lineages "Victoria". Note that one specimen sample was positive for both influenza A and B so the number started still remains 1839.
Time Frame Within the Southern hemisphere influenza seasons (May to October of each year 2011-2017)
Hide Outcome Measure Data
Hide Analysis Population Description
The analysis was performed on the specimen samples, among the Total Cohort, diagnosed with seasonal influenza B, reported in the ICGES database of Panama, within the Southern hemisphere influenza seasons (May to October of each year 2011-2017).
Arm/Group Title Influenza Virus Positive Group
Hide Arm/Group Description:
The group included specimen samples with a laboratory confirmed diagnosis of influenza A and/or B, reported in the Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) database of Panama, from January 2011 to December 2017.
Overall Number of Participants Analyzed 357
Measure Type: Count of Participants
Unit of Measure: Participants
V.(B/Brisbane/60/2008)vsVictoria-May-Oct 2011 Number Analyzed 0 participants
V.(B/Brisbane/60/2008)vsYamagata-May-Oct 2011 Number Analyzed 0 participants
V.(B/Brisbane/60/2008)vsVictoria-May-Oct 2012 Number Analyzed 172 participants
172
 100.0%
V.(B/Brisbane/60/2008)vsYamagata-May-Oct 2012 Number Analyzed 172 participants
0
   0.0%
Y.(B/Wisconsin/1/2010)vsVictoria-May-Oct 2013 Number Analyzed 0 participants
Y.(B/Wisconsin/1/2010)vsYamagata-May-Oct 2013 Number Analyzed 0 participants
Y.(B/Massachusetts/2/2012)vsVictoria-May-Oct 2014 Number Analyzed 54 participants
0
   0.0%
Y.(B/Massachusetts/2/2012)vsYamagata-May-Oct 2014 Number Analyzed 54 participants
54
 100.0%
Y.(B/Phuket/3073/2013)vsVictoria-May-Oct 2015 Number Analyzed 0 participants
Y.(B/Phuket/3073/2013)vsYamagata-May-Oct 2015 Number Analyzed 0 participants
V.(B/Brisbane/60/2008)vsVictoria-May-Oct 2016 Number Analyzed 0 participants
V.(B/Brisbane/60/2008)vsYamagata-May-Oct 2016 Number Analyzed 0 participants
V.(B/Brisbane/60/2008)vsVictoria-May-Oct 2017 Number Analyzed 131 participants
80
  61.1%
V.(B/Brisbane/60/2008)vsYamagata-May-Oct 2017 Number Analyzed 131 participants
51
  38.9%
Time Frame No safety data have been collected in the study.
Adverse Event Reporting Description There was no subject enrolment in the study. The study encompassed subject specimen samples reported in the ICGES database of Panama.
 
Arm/Group Title Influenza Virus Positive Group
Hide Arm/Group Description The group included specimen samples with a laboratory confirmed diagnosis of influenza A and/or B, reported in the Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) database of Panama, from January 2011 to December 2017.
All-Cause Mortality
Influenza Virus Positive Group
Affected / at Risk (%)
Total   0/0 
Hide Serious Adverse Events
Influenza Virus Positive Group
Affected / at Risk (%)
Total   0/0 
Hide Other (Not Including Serious) Adverse Events
Frequency Threshold for Reporting Other Adverse Events 0%
Influenza Virus Positive Group
Affected / at Risk (%)
Total   0/0 
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
Results Point of Contact
Layout table for Results Point of Contact information
Name/Title: GSK Response Center
Organization: GlaxoSmithKline
Phone: 866-435-7343
EMail: gskclinicalhd@gsk.com
Layout table for additonal information
Responsible Party: GlaxoSmithKline
ClinicalTrials.gov Identifier: NCT02885246    
Other Study ID Numbers: 205049
First Submitted: August 26, 2016
First Posted: August 31, 2016
Results First Submitted: February 11, 2020
Results First Posted: March 3, 2020
Last Update Posted: April 6, 2020